SparkMaster 2: New software automates analysis of calcium release events

A team of UC Davis and University of Oxford researchers have developed an innovative tool: SparkMaster 2.

AIFA’s horizon scanning 2024 predictions suggest an influx of ATMPs – Pharmaceutical Technology

The mid-year period marks a significant phase for horizon scanning activities that map the regulatory approval progress of innovative medicines within the EU. In May

May 30, 2024

US health care workers are at greater risk of suicide than non–health care workers

The risks of death by suicide for six healthcare worker (HCW).

September 28, 2023

Cybin Announces FDA Clearance to Initiate a Phase 2a Study of CYB004 in Generalized Anxiety Disorder | Psychedelic Invest

–Recently announced positive Phase 1 topline safety, pharmacokinetic (“PK”) and pharmacodynamic (“PD”) data show that intravenous (“IV”) CYB004 demonstrated robust and rapid-onset psychedelic effects at

January 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.